不活化ポリオ・ワクチンと狂犬病ワクチンの世界市場

不活化ポリオ・ワクチンと狂犬病ワクチンの世界市場は2030年までに15億米ドルに達する

2024年に12億米ドルと推定される不活化ポリオ・ワクチンと狂犬病ワクチンの世界市場は、2024～2030年の分析期間においてCAGR 3.5%で成長し、2030年には15億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである不活化ポリオワクチンは、CAGR 2.8%を記録し、分析期間終了時には9億7,130万米ドルに達すると予測されます。不活化狂犬病ワクチン分野の成長率は、分析期間中CAGR 4.9%と推定されます。

米国市場は3億2,350万米ドルと推定、中国はCAGR 6.4％で成長予測

米国の不活化ポリオ・ワクチンと狂犬病ワクチン市場は、2024年に3億2,350万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR6.4%を牽引し、2030年までに2億8,880万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.7%と予測されています。欧州では、ドイツがCAGR 2.0%で成長すると予測されています。

世界の不活化ポリオ・ワクチンと狂犬病ワクチン市場- 主要動向と促進要因まとめ

なぜ不活化ワクチンは世界の予防接種プログラムで重要性を増しているのか？

不活化ポリオ・ワクチンと狂犬病ワクチンは、世界の予防接種戦略において、特に疾病の撲滅や曝露後予防において、不可欠な役割を果たし続けています。不活化ポリオワクチン（IPV）は、ポリオウイルスの3つの血清型すべてを化学的に不活化したもので、経口ポリオワクチン（OPV）にはワクチン由来のポリオウイルスが発生するなどのリスクがあるため、現在ではほとんどの国の予防接種プログラムで優先的に使用されています。IPVは、高い免疫原性を維持しながらこのようなリスクを排除しており、WHOとGaviが主導する世界のポリオ撲滅活動の最終段階において不可欠なものとなっています。

同様に、不活化狂犬病ワクチンも、曝露前および曝露後の予防のためのゴールドスタンダードであり続けています。これらのワクチンは、細胞培養または胚培養卵をプラットフォームとしており、完全に非感染性であるため、子どもや妊婦のような脆弱な集団においても安全性が確保されています。これらのワクチンの採用は、イヌへの感染率が高いため、狂犬病が依然として公衆衛生上の重大な懸念となっているアジアやアフリカの流行国において極めて重要です。どちらのワクチンも、幅広い国際的ガイドラインやWHOの必須医薬品リストに含まれており、公衆衛生提供の枠組みにおける位置づけの恩恵を受けています。

製造技術革新と技術プラットフォームは、どのようにワクチンの入手可能性を形成しているのか？

最近のワクチン製造技術の進歩により、不活化ワクチンのスケーラビリティ、純度、安全性が向上しています。IPVでは、従来のサル腎細胞製造に代わり、ヴェロ細胞を用いた最新の細胞培養ベースの製造が導入され、より安定した生産量が得られ、汚染リスクも軽減されています。これらの技術革新により、小児および成人の予防接種プログラムに適した大規模生産が可能になりました。世界の需要に応えて、いくつかのメーカーはIPVとDTaP、HepB、Hib抗原を統合した混合ワクチンも開発しており、注射回数を減らし、小児の予防接種スケジュールにおけるコンプライアンスを向上させています。

不活化狂犬病ワクチンでは、精製技術やアジュバント製剤の改良により、有効性が向上し、反応原性が低下しています。皮内（ID）投与プロトコールは、免疫原性を損なうことなく、より少量のワクチンで済むため、特に資源に乏しい環境において浸透してきています。コールドチェーンの最適化も重要なトレンドとして浮上しており、遠隔地や資源不足の地域での温度変動に耐えうる耐熱性製剤が開発されています。このような製剤と送達の強化は、先進国と発展途上国との間のアクセシビリティ・ギャップを埋める上で不可欠です。

需要が集中している地域と新たな使用事例は？

IPVの需要は、OPVから移行しつつある地域、特に世界ポリオ撲滅推進計画（GPEI）の支援を受けている中所得国で最も高いです。流行が一部の地域に限られている現在、監視システムはIPVに基づく封じ込め戦略に急速に移行しています。また、特に予防接種率が低い地域で、ワクチン由来のポリオウイルス株による集団発生に対処するため、不活化ワクチンが世界的に備蓄されています。高所得国では、IPVは小児期の定期予防接種の主流であり、投与を簡便化するために混合ワクチンで接種されることが多いです。

不活化狂犬病ワクチンは、疾病負担の大きいアジア太平洋地域とサハラ以南のアフリカで特に高い普及率を示しています。各国政府と国際保健機関は、曝露後予防（PEP）へのアクセス拡大に取り組んでおり、農村部の保健センターや救急外来での利用が改善されています。また、獣医師、動物取扱業者、旅行者、実験室職員などの高リスクグループに対する曝露前ワクチン接種にも注目が集まっています。IDレジメンの使用は、特にインド、タイ、フィリピンでの狂犬病発生時の集団予防接種キャンペーンを可能にする上で極めて重要です。さらに、国際的な旅行プロトコルは、特に流行地域を訪れる旅行者のポリオワクチンと狂犬病ワクチンの需要に影響を及ぼしています。

不活化ポリオ・ワクチンと狂犬病ワクチン市場の成長はいくつかの要因によって牽引されている...

主に、世界の撲滅活動の一環として、経口ポリオワクチンが段階的に不活化代替ワクチンに切り替えられていることと、IPVの普遍的な予防接種プログラムに対する各国の投資が増加していることが要因となっています。Gaviが支援する予防接種インフラが拡大し、IPVが小児用混合ワクチンに統合されたことで、ユーザー基盤が大幅に拡大し、ロジスティクスが合理化されました。これと並行して、狂犬病の報告件数が増加し、流行国では曝露後治療を適時に受けられないことから、不活化狂犬病ワクチン、特に皮内投与による費用対効果の高いワクチンへの需要が高まっています。

もう一つの成長要因は、世界の旅行や移住の急増、旅行関連の感染リスクに対する意識の高まりであり、これによって曝露前ワクチン接種の普及が進んでいます。ワクチン製造と耐熱性の技術的向上は、製造能力の分散化と相まって、特に低・中所得国でのコスト削減と地域アクセスの改善に役立っています。さらに、WHOの事前資格要件や不活化ワクチンに関する規制の迅速化など、国内外での政策的な義務付けが、公衆衛生当局によるワクチン調達を後押ししています。両疾患に対する備蓄や緊急対応能力を支援するための官民パートナーシップやドナーからの資金提供の出現も、市場の継続的拡大をさらに後押ししています。

セグメント

ワクチン（不活化ポリオワクチン,不活化狂犬病ワクチン）;不活化法（溶剤洗浄法,放射線法, pH濃縮,加熱不活化,その他の不活化法）;年齢層（小児科,成人）;流通チャネル別（政府,民間）

調査対象企業の例（注目の44社）

• Bavarian Nordic A/S
• Bharat Biotech International Ltd.
• Biological E Limited
• BIO-MED Pvt. Ltd.
• Boehringer Ingelheim International GmbH
• Cadila Healthcare Limited（Zydus）
• CanSino Biologics Inc.
• Chiron Behring Vaccines Pvt. Ltd.
• CSL Limited
• Daiichi Sankyo Company, Limited
• Elanco Animal Health Inc.
• GlaxoSmithKline plc
• Indian Immunologicals Ltd.
• Johnson & Johnson Services Inc.
• Kedrion Biopharma Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi Pasteur
• Serum Institute of India Pvt. Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

無料アップデート弊社のお客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Inactivated Polio and Rabies Vaccines Market to Reach US$1.5 Billion by 2030

The global market for Inactivated Polio and Rabies Vaccines estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Inactivated Polio Vaccines, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$971.3 Million by the end of the analysis period. Growth in the Inactivated Rabies Vaccines segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$323.5 Million While China is Forecast to Grow at 6.4% CAGR

The Inactivated Polio and Rabies Vaccines market in the U.S. is estimated at US$323.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$288.8 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Inactivated Polio and Rabies Vaccines Market - Key Trends & Drivers Summarized

Why Are Inactivated Vaccines Regaining Importance in Global Immunization Programs?

Inactivated polio and rabies vaccines continue to play an indispensable role in global immunization strategies, particularly in the context of disease eradication and post-exposure prophylaxis. Inactivated polio vaccines (IPV), which contain a chemically inactivated version of all three poliovirus serotypes, are now the preferred option in most national immunization programs due to the risks associated with oral polio vaccine (OPV), including vaccine-derived poliovirus outbreaks. IPV eliminates this risk while maintaining high immunogenicity, making it essential in the final phase of global polio eradication efforts led by the WHO and Gavi.

Similarly, inactivated rabies vaccines remain the gold standard for both pre- and post-exposure prophylaxis. These vaccines are derived from cell culture or embryonated egg platforms and are entirely non-infectious, ensuring safety even in vulnerable populations such as children and pregnant women. Their adoption is critical in endemic countries across Asia and Africa, where rabies remains a significant public health concern due to high rates of canine transmission. Both vaccine categories benefit from broad international guidelines and inclusion in WHO Essential Medicines lists, anchoring their place in public health delivery frameworks.

How Are Manufacturing Innovations and Technology Platforms Shaping Vaccine Availability?

Recent advancements in vaccine production technologies have enhanced the scalability, purity, and safety of inactivated vaccines. For IPV, modern cell culture-based manufacturing using Vero cells has replaced traditional monkey kidney cell production, yielding more consistent output and reducing contamination risks. These innovations allow large-scale production suitable for both pediatric and adult immunization programs. In response to global demand, several manufacturers have also developed combination vaccines that integrate IPV with DTaP, HepB, or Hib antigens, reducing the number of injections and improving compliance in pediatric immunization schedules.

For inactivated rabies vaccines, improved purification techniques and adjuvant formulations have resulted in higher efficacy and reduced reactogenicity. Intradermal (ID) administration protocols have gained ground, especially in resource-limited settings, as they require smaller vaccine volumes without compromising immunogenicity. Cold chain optimization has also emerged as a crucial trend, with thermostable formulations under development that can tolerate temperature fluctuations in remote or under-resourced areas. These enhancements in formulation and delivery are essential in bridging the accessibility gap between developed and developing nations.

Where Is Demand Concentrated and What Are the Emerging Use Cases?

The demand for IPV is highest in regions transitioning away from OPV, particularly in middle-income countries supported by the Global Polio Eradication Initiative (GPEI). With endemic transmission now limited to a few regions, surveillance systems are rapidly shifting to IPV-based containment strategies. Inactivated vaccines are also being stockpiled globally to manage outbreaks caused by vaccine-derived poliovirus strains, especially in areas with low immunization coverage. In high-income nations, IPV is a mainstay in routine childhood immunization, often delivered in combination vaccines to simplify administration.

Inactivated rabies vaccines show particularly strong uptake in Asia-Pacific and Sub-Saharan Africa, where the disease burden is high. Governments and global health organizations are working to expand access to post-exposure prophylaxis (PEP), with improved availability in rural health centers and emergency departments. There is also a growing focus on pre-exposure vaccination for high-risk groups such as veterinarians, animal handlers, travelers, and laboratory personnel. The use of ID regimens has been critical in enabling mass vaccination campaigns during rabies outbreaks, particularly in India, Thailand, and the Philippines. Additionally, international travel protocols are influencing demand for both polio and rabies vaccines, especially in travelers visiting endemic regions.

The Growth in the Inactivated Polio and Rabies Vaccines Market Is Driven by Several Factors…

It is driven primarily by the phasing out of oral polio vaccines in favor of inactivated alternatives as part of global eradication initiatives, coupled with increased national investments in universal IPV immunization programs. The expansion of Gavi-supported immunization infrastructure and the integration of IPV into combination pediatric vaccines have significantly broadened the user base and streamlined logistics. In parallel, the rise in reported cases of rabies and limited access to timely post-exposure treatment in endemic countries are fueling sustained demand for inactivated rabies vaccines, particularly through intradermal, cost-effective administration.

Another growth lever is the surge in global travel, migration, and awareness of travel-related infectious risks, which has increased the uptake of pre-exposure vaccination. Technological improvements in vaccine production and thermostability, combined with decentralization of manufacturing capabilities, are helping reduce costs and improve regional access, especially across low- and middle-income countries. Furthermore, national and international policy mandates, such as WHO prequalification requirements and regulatory fast-tracking for inactivated vaccines, are boosting procurement by public health authorities. The emergence of public-private partnerships and donor funding to support stockpiling and emergency response capacity for both diseases adds an additional layer of support to the market’s continued expansion.

SCOPE OF STUDY:

The report analyzes the Inactivated Polio and Rabies Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Vaccine (Inactivated Polio Vaccines, Inactivated Rabies Vaccines); Inactivation Method (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Other Inactivation Methods); Age Group (Pediatrics, Adults); By Distribution Channel (Government, Private)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Bavarian Nordic A/S
• Bharat Biotech International Ltd.
• Biological E Limited
• BIO-MED Pvt. Ltd.
• Boehringer Ingelheim International GmbH
• Cadila Healthcare Limited (Zydus)
• CanSino Biologics Inc.
• Chiron Behring Vaccines Pvt. Ltd.
• CSL Limited
• Daiichi Sankyo Company, Limited
• Elanco Animal Health Inc.
• GlaxoSmithKline plc
• Indian Immunologicals Ltd.
• Johnson & Johnson Services Inc.
• Kedrion Biopharma Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi Pasteur
• Serum Institute of India Pvt. Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Inactivated Polio and Rabies Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Global Emphasis on Eradicating Polio Sustains Long-Term Demand for Inactivated Polio Vaccines
  • Rising Incidence of Rabies in Endemic Regions Spurs Demand for Human Rabies Vaccination Programs
  • Expanded Government Immunization Campaigns Strengthen the Market Outlook for Inactivated Viral Vaccines
  • WHO and GAVI-Led Polio Eradication Initiatives Drive Mass Procurement of IPV Doses
  • Urbanization and Increased Human-Animal Contact Raise Risk Exposure and Accelerate Rabies Vaccine Uptake
  • Global Shift from OPV to IPV in Routine Immunization Expands the Addressable Market for Inactivated Polio Vaccines
  • Regulatory Endorsement of Prequalified IPV Products Facilitates Broader Market Penetration in Low-Income Countries
  • Travel-Related Rabies and Polio Risk Awareness Drives Adoption of Pre-Exposure Prophylaxis Vaccinations
  • Growing Focus on Needle-Free and Intradermal Delivery Innovations Enhances Adoption of Inactivated Vaccines
  • Post-Exposure Prophylaxis Requirements in Rabies-Exposed Individuals Generate Consistent Market Demand
  • Cold Chain Improvements in Emerging Markets Expand Reach of Temperature-Sensitive Inactivated Vaccines
  • Private Sector Participation in Rabies Vaccination Campaigns Expands Market Beyond Public Health Channels
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Inactivated Polio and Rabies Vaccines Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Inactivated Polio and Rabies Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Inactivated Polio Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Inactivated Polio Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Inactivated Polio Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Inactivated Rabies Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Inactivated Rabies Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Inactivated Rabies Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Government by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Government by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Government by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Private by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Private by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Private by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Solvent Detergent Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Solvent Detergent Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Solvent Detergent Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Radiation Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Radiation Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Radiation Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for pH Concentration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for pH Concentration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for pH Concentration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Heat Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Heat Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Heat Inactivation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Inactivation Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Inactivation Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other Inactivation Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Pediatrics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Pediatrics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Pediatrics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Adults by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• JAPAN
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• CHINA
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• EUROPE
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Inactivated Polio and Rabies Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• FRANCE
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• GERMANY
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 137: UK Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Inactivated Polio and Rabies Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• INDIA
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 212: India Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Inactivated Polio and Rabies Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Inactivated Polio and Rabies Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030
• AFRICA
  • Inactivated Polio and Rabies Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Inactivated Polio and Rabies Vaccines by Vaccine - Inactivated Polio Vaccines and Inactivated Rabies Vaccines Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Vaccine - Percentage Breakdown of Value Sales for Inactivated Polio Vaccines and Inactivated Rabies Vaccines for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Government and Private Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Inactivated Polio and Rabies Vaccines by By Distribution Channel - Percentage Breakdown of Value Sales for Government and Private for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Inactivated Polio and Rabies Vaccines by Inactivation Method - Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Inactivation Method - Percentage Breakdown of Value Sales for Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation and Other Inactivation Methods for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Inactivated Polio and Rabies Vaccines by Age Group - Pediatrics and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Inactivated Polio and Rabies Vaccines by Age Group - Percentage Breakdown of Value Sales for Pediatrics and Adults for the Years 2015, 2025 & 2030

IV. COMPETITION